Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studying KLF4 gene methylation as colorectal polyps progress toward adenomas and cancer

Measures KLF4 methylation in colon tissue taken during routine colonoscopy in adults.

Plain-language title generated from the registry record
Registry title: KLF4 Epigenetic Modulation

Key facts

Where
Reggio Emilia, ItalySee the site

Where in Italy

  • Azienda USL IRCCS di Reggio EmiliaReggio Emilia, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Azienda USL Reggio Emilia - IRCCS
Trial code
NCT07901335
Record updated
10 November 2026
Original description
The study investigates the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. Quantitative KLF4 methylation will be assessed in colorectal tissue samples obtained during routine colonoscopy, together with KLF4 gene expression and its correlation with methylation status in matched tissue samples. The study will also evaluate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation.Read full original descriptionShow less

KLF4 Epigenetic Modulation During Polyps-adenoma Progression

The study investigates the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. Quantitative KLF4 methylation will be assessed in colorectal tissue samples obtained during routine colonoscopy, together with KLF4 gene expression and its correlation with methylation status in matched tissue samples. The study will also evaluate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation.

Inclusion: Patients undergoing routine colonoscopy; > 18 years of age; Diagnosed by S.C. Anatomia Patologica, AUSL-IRCCS Reggio Emilia.

Exclusion: Concomitant diagnosis of colorectal carcinoma.

ClinicalTrials.gov NCT07901335